FDA Releases Draft Guidance on Pediatric Clinical Investigations

Summary

The FDA has made available a draft guidance document, E11(R1) Addendum, which updates the ICH E11 guidance on clinical investigations of medicinal products in the pediatric population, providing clarification and current regulatory perspectives on global pediatric drug development.